A systematic study on generating simian immunodeficiency virus (SIV)-based
vectors was carried out. The goal was to generate helper-free, replication-
defective SIVmac-based vectors at high titers. The general approach was to
cotransfect into human 293T cells a plasmid carrying the vector construct a
long with two helper plasmids that together expressed the SIVmac virion pro
teins. Initial vectors carried the bacterial beta -galactosidase gene (beta
-gal). These vectors had a technical difficulty: 'pseudotransduction'' of
beta -gal protein produced during the 293T cell transfections. As a result,
infection of cultures with these vector stocks also resulted in passive tr
ansfer into, and X-gal staining of, cells that had not actually been infect
ed by the vector. A second generation of vectors expressing the enhanced je
llyfish green fluorescence protein (EGFP) was not subject to this artifact.
A systematic study of the SIVmac-based EGFP vectors was carried out. Helpe
r-free Vector stocks were obtained when helper plasmids lacking the SIVmac
packaging signals were used. By employing envelope helper plasmids derived
from different SIVmac isolates, it was possible to generate SIVmac-based ve
ctors pseudotyped with envelope proteins of different cell tropism. Optimiz
ation of Vector and helper plasmid structures, transfection conditions, and
infection procedures ultimately yielded vector titers in excess of 10(6)/m
l. (C) 2001 Academic Press.